Volume | 11 005 |
|
|||||
Actualités | - |
Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
Lexaria Bioscience Corporation | LEXXW | NASDAQ | Warrant |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
0,23 | 0,23 | 0,28 | 0,2597 | 0,201 |
Transactions Totales | Volume échangé | VWAP | Volume Financier | Volume en moyenne |
---|---|---|---|---|
89 | 11 005 | 0,2595019 | 2 856 | - |
Dernière Transaction | Type | Quantités échangées | Prix transaction | Devise |
---|---|---|---|---|
21:00:00 | 1 600 | 0,2597 | USD |
Bilan Comptable
Capitalisation Boursière | Actions en Circulation | Float | Chiffre d'affaires | Bénéfice/Perte | BPA | Ratio Cours sur Bénéfices |
---|---|---|---|---|---|---|
0 | 0,00 | - | 464k | -5,8M | - | - |
Short Interest | Dividendes Par Action | Rendement du Dividende | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
plus d’informations financières »
Actualités Lexaria Bioscience
Date | Heure | Source | Titre |
---|---|---|---|
05/2/2025 | 22:45 | Edgar (US Regulatory) | Form 8-K - Current report |
05/2/2025 | 22:08 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
31/1/2025 | 06:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
22/1/2025 | 22:06 | Edgar (US Regulatory) | Form S-3 - Registration statement under Securities Act of.. |
15/1/2025 | 18:02 | Edgar (US Regulatory) | Form 8-K - Current report |
10/1/2025 | 20:19 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
03/1/2025 | 18:48 | Edgar (US Regulatory) | Form 8-K - Current report |
18/12/2024 | 19:08 | Edgar (US Regulatory) | Form 8-K - Current report |
16/12/2024 | 22:05 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration.. |
26/11/2024 | 19:01 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
14/11/2024 | 22:11 | Edgar (US Regulatory) | Form SC 13G/A - Statement of Beneficial Ownership by Certain.. |
18/10/2024 | 22:42 | Edgar (US Regulatory) | Form 8-K - Current report |
Forum Lexaria Bioscience
Aucune Discussion TrouvéeAjouter une Discussion
Historiques
Période | Ouver. | Haut | Bas | VWAP | Moyenne Vol. Quot. | Variation | % |
---|---|---|---|---|---|---|---|
1 semaine | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
1 mois | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
3 mois | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
6 mois | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
1 an | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
3 ans | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
5 ans | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
NASDAQ:LEXXW -
What is the current Lexaria Bioscience Corporation share price?
The current share price of Lexaria Bioscience Corporation is US$ 0,2597
What is the 1 year trading range for Lexaria Bioscience Corporation share price?
Lexaria Bioscience Corporation has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the reporting currency for Lexaria Bioscience Corporation?
Lexaria Bioscience Corporation reports financial results in USD
What is the latest annual turnover for Lexaria Bioscience Corporation?
The latest annual turnover of Lexaria Bioscience Corporation is USD 464k
What is the latest annual profit for Lexaria Bioscience Corporation?
The latest annual profit of Lexaria Bioscience Corporation is USD -5,8M
What is the registered address of Lexaria Bioscience Corporation?
The registered address for Lexaria Bioscience Corporation is 100-740 MCCURDY RD, KELOWNA, BRITISH COLUMBIA, V1X 2P7
What is the Lexaria Bioscience Corporation website address?
The website address for Lexaria Bioscience Corporation is www.lexariabioscience.com
Which industry sector does Lexaria Bioscience Corporation operate in?
Lexaria Bioscience Corporation operates in the CRUDE PETROLEUM & NATURAL GS sector